Michael Crowley Bio Rad Laboratories, Inc. (BIO) insider trading activity

Michael Crowley is EVP, GBL Commercial Operations of BIO-RAD LABORATORIES, INC.. Currently has a direct ownership of 8,171 shares of BIO, which is worth approximately $2.56 Million. The most recent transaction as insider was on Sep 03, 2022, when has been sold 241 shares (Bio-Rad A Common Stock) at a price of $478.32 per share, resulting in proceeds of $115,275. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.17K

0% 3M change

0% 12M change

Total Value Held $2.56 Million

Michael Crowley Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 03 2022	SELL Payment of exercise price or tax liability	$115,275 $478.32 p/Share	241 Reduced 3.9%	5,936 Bio-Rad A Common Stock
Sep 03 2022	BUY Exercise of conversion of derivative security	-	557 Added 8.27%	6,177 Bio-Rad A Common Stock
Sep 02 2022	SELL Payment of exercise price or tax liability	$71,748 $478.32 p/Share	150 Reduced 2.6%	5,620 Bio-Rad A Common Stock
Sep 02 2022	BUY Exercise of conversion of derivative security	-	433 Added 6.98%	5,770 Bio-Rad A Common Stock
Sep 01 2022	SELL Payment of exercise price or tax liability	$68,561 $486.25 p/Share	141 Reduced 2.57%	5,337 Bio-Rad A Common Stock
Sep 01 2022	BUY Exercise of conversion of derivative security	-	405 Added 6.88%	5,478 Bio-Rad A Common Stock
Sep 07 2021	SELL Payment of exercise price or tax liability	$240,283 $806.32 p/Share	298 Reduced 5.55%	5,073 Bio-Rad A Common Stock

Sep 07 2021	BUY Exercise of conversion of derivative security	-	600 Added 10.05%	5,371 Bio-Rad A Common Stock
Sep 05 2021	SELL Payment of exercise price or tax liability	$244,271 $819.7 p/Share	298 Reduced 5.88%	4,771 Bio-Rad A Common Stock
Sep 05 2021	BUY Exercise of conversion of derivative security	-	600 Added 10.58%	5,069 Bio-Rad A Common Stock
Sep 04 2021	SELL Payment of exercise price or tax liability	$244,271 $819.7 p/Share	298 Reduced 6.25%	4,469 Bio-Rad A Common Stock
Sep 04 2021	BUY Exercise of conversion of derivative security	-	600 Added 11.18%	4,767 Bio-Rad A Common Stock
Sep 03 2021	SELL Payment of exercise price or tax liability	$227,057 $819.7 p/Share	277 Reduced 6.23%	4,167 Bio-Rad A Common Stock
Sep 03 2021	BUY Exercise of conversion of derivative security	-	557 Added 11.14%	4,444 Bio-Rad A Common Stock
Sep 02 2021	SELL Payment of exercise price or tax liability	$177,541 $825.77 p/Share	215 Reduced 5.24%	3,887 Bio-Rad A Common Stock
Sep 02 2021	BUY Exercise of conversion of derivative security	-	433 Added 9.55%	4,102 Bio-Rad A Common Stock
Aug 09 2021	SELL Open market or private sale	$2,265,780 $755.26 p/Share	3,000 Reduced 44.98%	3,669 Bio-Rad A Common Stock
Aug 09 2021	BUY Exercise of conversion of derivative security	$418,680 $139.56 p/Share	3,000 Added 31.03%	6,669 Bio-Rad A Common Stock
Dec 15 2020	SELL Open market or private sale	$217,171 $580.67 p/Share	374 Reduced 9.25%	3,669 Bio-Rad A Common Stock

Michael Crowley

EVP, GBL Commercial Operations

Hercules, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BIO shares.

Notify only if

Value

Insider Trading

Get notified when an Bio Rad Laboratories, Inc. insider buys or sells BIO shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIO-RAD LABORATORIES, INC.

Track Activities on BIO

Account